$MSCI

JPMorgan Adjusts Price Target on MSCI to $685 From $700

JPMorgan reduced its price target for MSCI from $700 to $685. Deutsche Bank also lowered its target for MSCI from $729 to $684. MSCI's stock is currently trading at $560.82, down 1.27% in the last 5 days.

Original reporting
Published Oct 14, 2026, 9:52 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 14, 2026, 10:08 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$MSCI
Bearish
medium confidence
Mentioned
$MSCI
Relevance
5/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$MSCIBearishLow
01

Why it matters

The downgrade may prompt short-term traders to sell MSCI shares, while long-term investors may view it as a buying opportunity if they disagree with the analyst's view.

02

Market read

Analyst target changes are a common catalyst for short-term price moves in large-cap stocks.

03

What to watch

Recent client wins and stable subscription revenue may offset the downgrade.

Relevance 5/10Novelty 5/10Timing: pre-market today

Background

JPMorgan periodically updates price targets for large-cap equities based on valuation and earnings outlook.

Company-level read

Ticker impact

$MSCIBearishMedium confidence
Context

JPMorgan lowered MSCI's price target to $685 from $700.

Expected impact

likely downward pressure as investors price in the lower target

Evidence & confidence

Analyst target reductions often lead to short-term sell pressure, especially when the cut is 2%.

Market effects

May signal a more cautious outlook for the broader index and data analytics sector.

Primarily U.S. market impact; limited effect on other regions.

Modest, as MSCI is a benchmark provider used worldwide.

Counterpoint

The target cut could be an overreaction; MSCI's fundamentals remain strong.

Key entities

  • MSCI Inc.

    Provider of investment decision support tools and indexes.

  • JPMorgan

    Investment bank issuing the price target revision.

Related articles

Med

India's Swiggy pares gains ahead of exit from MSCI indexes

Swiggy's shares closed 2.5% higher on Friday, after rising as much as 5.61%, ahead of being removed from MSCI indexes. The firm faces an estimated $360 million in passive outflows, according to Nuvama's Abhilash Pagaria. Swiggy's shares have fallen 28.5% this year, underperforming the Nifty mid-cap 100 index.

MedAI 8/10

MSCI August Rebalance and Jio IPO Approval to Test Market

MSCI's August 2026 index rebalance, effective September 1, 2026, will shift $1.5B in passive funds, adding Laurus Labs, Lenskart, Adani Energy, and Billionbrains, while removing Balkrishna, SBI Cards, and Astral. Jio Platforms' IPO, approved by SEBI, aims to raise ₹27,500 crore. New closing auction rules may increase volatility.

$MSTRMed

MicroStrategy Bitcoin: MSCI Index Review Could Pressure Shares

MSCI is reviewing rules that could remove MicroStrategy from global equity indexes, focusing on companies primarily engaged in asset accumulation. MicroStrategy shares rose 35% in a week but are down 60% year-over-year. The review uses five financial metrics to assess eligibility, potentially affecting demand and capital access for MicroStrategy's Bitcoin purchases.

$MSCIHighAI 8/10

Are Wall Street Analysts Bullish on MSCI Stock?

MSCI Inc. (MSCI), a data and analytics provider, has underperformed the broader market over the past year. Its shares fell 10.1% on July 21 after raising its 2026 operating expense forecast, citing higher costs. Analysts expect MSCI's adjusted EPS to grow 13.5% YoY to $19.61. The consensus rating is 'Strong Buy' with a mean price target of $690.44, a 22.5% premium to current levels.